Cite
HARVARD Citation
Puskarich, M. et al. (2021). Pharmacometabolomics identifies candidate predictor metabolites of an L‐carnitine treatment mortality benefit in septic shock. Clinical and translational science. 14 (6), pp. 2288-2299. [Online].